Enjoy complimentary customisation on priority with our Enterprise License!
The global incubators, inhalators, respirators, resuscitators, and other breathing devices market size is estimated to grow by USD 10.89 billion, at a CAGR of 7.67% between 2023 and 2028.
The array of new launches across product lines provides end-users with various options, which help stimulate the overall product demand for breathing devices. Hence, the manufacturers of breathing devices are finding opportunities to convert this increased demand into a continuous cycle of innovation and improvisation for enhanced products. Vendors are constantly focusing on product innovation, and R&D. Such initiatives enable vendors to efficiently meet the demands of end-users and improve product performance and features to suit the requirements of changing healthcare scenarios. All these factors are driving the sales of new products and accelerating the growth of the global incubators, inhalators, respirators, resuscitators, and other breathing devices market during the forecast period.
Technavio has segmented the market into Application, End-user, and Geography
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018 - 2022, besides analyzing the current market scenario.
To learn more about this report, Download Report Sample
The market share growth by the asthma segment will be significant during the forecast period. Asthma affects people of all ages and is a chronic lung disease. It is caused by inflammation in the airways and muscles being tightened, which makes it hard to breathe. Inhalators are used by patients suffering from asthma.
Get a glance at the market contribution of various segments Download PDF Sample
The asthma segment was the largest and was valued at USD 5.18 billion in 2018. Many factors play an important role in the development of asthma, including allergies, family history of asthma, smoking, air pollution, and various other contributors. According to the World Health Organization, asthma affected an estimated 262 million people in 2019 and caused 455,000 deaths across the globe. Using inhaled medicinal products can help control asthma symptoms, enabling patients to lead active lives. Sleep disturbance, tiredness during the daytime, and reduced concentration can occur in people who do not receive adequate treatment for asthma. In some cases, asthma attacks can also be fatal. Severe asthma attacks can deprive patients of sufficient oxygen in their lungs and may lead to breathing cessation. Thus, the high number of asthma cases is expected to fuel the demand for inhalator devices, thereby driving the market during the forecast period.
Resuscitators, incubators, inhalators, respirators, and other breathing devices are extensively used across healthcare settings such as hospitals, clinics, and ambulatory care settings. These devices ensure an optimum supply of oxygen for patients during healthcare treatments. For instance, oxygen inhalators regulate the flow of oxygen for patients and protect patients from hyperoxia. Similarly, resuscitators are used to inflate the lungs of unconscious patients who are unable to breathe. Further, the use of disposable breathing devices such as disposable resuscitators and disposable respirators is helping healthcare settings control and reduce the incidence of hospital-associated infections (HAI). Thus, the demand for advanced breathing devices has increased across healthcare settings, which is driving the revenue growth of the market segments during the forecast period.
Pharmaceutical companies use breathing devices significantly as personal protective equipment. Breathing devices such as N95 respirators and P100 respirators help pharmaceutical companies maintain safety at their workplace. Employees and workers in pharmaceutical companies are often exposed to risky environments that can adversely impact their health. In addition, the presence of stringent regulations and policies enforced by agencies such as the Occupational Safety and Health Administration (OSHA), the European Union (EU), and the US FDA has mandated the maintenance of safe working conditions and maintenance of a sufficient supply of personnel protective equipment for pharmaceutical companies. These factors have increased the demand for breathing devices such as respirators as personnel protective equipment across pharmaceutical companies. Hence, the market research and growth in pharmaceutical production and strict policies have helped drive the revenue growth of the pharmaceutical companies segment in the market during the forecast
For more insights about the market share of various regions Download PDF Sample now!
Europe is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. Europe is the dominant revenue contributor to the global incubators, inhalators, respirators, resuscitators, and other breathing devices market. Germany, the UK, and France are the leading revenue-generating countries in the region. The market in Europe is dominated by prominent vendors such as Ambu AS, Dragerwerk AG and Co. KGaA, Hamilton Medical AG, Koninklijke Philips NV, and others. These vendors are constantly upgrading their products as per the requirements of end-users. The increasing prevalence of chronic obstructive pulmonary disorders (COPD) in Europe has surged the demand for cardiac surgeries, including for pediatric patients. This has propelled the sales of breathing devices for preventing hypoxemia.
In addition, demand for breathing devices as personnel protective equipment across pharmaceutical companies has increased in Europe due to market growth and trends in pharmaceutical production. The rise in marketing authorizations has surged drug production across pharmaceutical companies, which has increased the demand for personnel protective breathing devices such as respirators in Europe. Thus, the market is expected to be in a dominant position during the market forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The market analysis and report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
3M Co - The company offers breathing devices such as 3M Versaflo Air Purifying Respirators.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, market trends and analysis, and challenges.
Increasing number of hospitalizations and surgical treatments is notably driving the market growth. The rising prevalence of various lifestyle and chronic diseases, such as cancer, asthma, cardiovascular diseases (CVDs), diabetes, COPD, bone diseases, thrombosis, liver diseases, and renal diseases, is increasing the number of hospital visits for various diagnostic and therapeutic purposes. In certain cases, such as COPD, hospitalization is recommended by medical professionals for proper monitoring of patients. In such cases, breathing devices such as inhalators, incubators, and resuscitators are required as a part of the treatment process and to provide surgical care to patients.
However, In certain cases, surgeries are recommended by healthcare professionals as a part of treating and managing various medical conditions such as cancer, malignant tumours, childbirth, nervous system disorders, joint fractures, and CVDs, among others. Growth in hospitalization associated with surgical procedures for various medical conditions is leading to increasing demand for breathing devices, which is fueling the growth of the market during the forecast period.
The surge in demand for disposable breathing devices is an emerging trend shaping the market growth. A disposable breathing device is a single-use device used by patients, healthcare practitioners, and pharmaceutical employees. The commonly used disposable breathing devices include disposable respirators and disposable resuscitators. The growing preference for these devices is attributed to their infection-controlling qualities and ease of use. Disposable breathing devices are used extensively in healthcare settings to prevent the risk of infection transmission and reduce HAIs. The increasing popularity of these devices has led vendors to constantly invest in product R&D and innovations to update their product portfolios.
Moreover, some of the commercialized disposable breathing devices available in the market include The BAG II Disposable Resuscitator offered by LAERDAL MEDICAL AS (LAERDAL MEDICAL), Ambu SPUR II - Disposable Resuscitator offered by Ambu AS, 3M Particulate Respirator 8210 offered by 3M Co., and ONE-Fit Molded Cup (NIOSH) offered by Honeywell International Inc. Thus, the surge in demand for disposable devices is expected to positively affect the growth of the market during the forecast year.
The high threat from counterfeit products is a significant challenge hindering market growth. The threat of counterfeit products remains high, especially in emerging economies, which is attributed to the lack of a well-defined regulatory framework. Such instances lead to ineffective diagnostic results, which can hamper the brand image of established products. Counterfeit breathing devices carry the markings of appropriate standards such as CE and the National Institute for Occupational Safety and Health (NIOSH). However, these products display false claims and fall under the non-conforming, non-compliant, and sub-standard categories.
Moreover, The lack of legislation to subdue counterfeit activities, especially in emerging countries such as China, India, and Thailand, is a challenge for vendors. In addition, a lack of surveillance in local supply chains can lead to tampering and repackaging of products. Vendors are incurring additional costs in curtailing such grey market activities, which is intensifying the cost pressures and hampering the revenue growth of the market during the forecast period.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Global Incubators, Inhalators, Respirators, Resuscitators, and Other Breathing Devices Market Customer Landscape
The incubators, inhalators, respirators, resuscitators, and other breathing devices market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and market growth and forecasting opportunities from 2018 to 2018
Incubators, Inhalators, Respirators, Resuscitators, and Other Breathing Devices Market Scope |
|
Report Coverage |
Details |
Page number |
173 |
Base year |
2023 |
Historic period |
2018-2022 |
Market forecasting period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.67% |
Market Growth 2024-2028 |
USD 10.89 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
6.58 |
Regional analysis |
Europe, North America, Asia, and Rest of World (ROW) |
Performing market contribution |
Europe at 37% |
Key countries |
US, Germany, UK, France, and China |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
3M Co., Ambu AS, Ansell Ltd., Beurer GmbH, Cardinal Health Inc., Dragerwerk AG and Co. KGaA, Flexicare Group Ltd., General Electric Co., Hamilton Bonaduz AG, Honeywell International Inc., HUM Systems GmbH, Kimberly Clark Corp., Koninklijke Philips N.V., Laerdal Medical AS, LIFE Corp., Medline Industries LP, Medtronic Plc, OMRON Corp., Phoenix Medical Systems P Ltd., Prestige Ameritech, and Zurich Corp. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.